Sunita Patruni

MD
Medical Oncology and Hematology

Cancers Treated:

Breast Cervical Colon Colorectal Esophageal Gallbladder & Bile Duct Kidney Liver Lung Pancreatic Prostate

Specializing In:

Hematologic Malignancies Classic Hematology

About Sunita Patruni

Biography:

Dr. Patruni is a Medical Oncologist and Hematologist at Roswell Park Comprehensive Cancer Center. She received her Bachelor of Science from the University of Illinois Urbana-Champaign and her Doctor of Medicine from St. George's University. Dr. Patruni completed her residency in Internal Medicine at Allegheny Health Network in Pittsburgh, PA and her fellowship in Hematology/Oncology at Northwell Health in New Hyde Park, NY where she also served as Chief Fellow.

Dr. Patruni has dedicated her time to research that focuses on health disparities in cancer treatment and novel treatment strategies for NSCLC and pancreatic cancer. Her work has been presented at national meetings and published in peer-reviewed journals.

Dr. Patruni treats both solid and hematologic malignancies with a special interest in cancers of the GI tract.

Positions

Roswell Park Care Network
  • Assistant Professor of Oncology
  • Department of Hematology and Oncology
  • Roswell Park Hematology Oncology Southtowns

Background

Education and Training:

  • 2017- MD - St. George's University, Grenada, West Indies

Residency:

  • 2017-2020 - Internal Medicine, Allegheny Health Network, Pittsburgh, PA

Fellowship:

  • 2020-2023 - Hematology/Oncology, Northwell Health, New Hyde Park, NY

Board Certification:

  • Internal Medicine - American Board of Internal Medicine

Professional Memberships:

  • ASCO
  • ASH

Honors & Awards:

  • 2022-2023 - Chief Hematology/Oncology Fellow

Publications

Patruni, Sunita, et al. “Immunotherapy in the Management of Esophagogastric Cancer: A Practical Review.” JCO Oncology Practice, vol. 19, no. 3, 21 Nov. 2022, pp. 107–115, https://doi.org/10.1200/op.22.00226.

Hines, Adam M., et al. “A Case Report of EGFR L861Q Mutation in Synchronous de Novo Small Cell and Non-Small Cell Lung Cancer: Molecular Interrogation Identifies Origin and Potential Options for Targeted Therapy.” Precision Cancer Medicine, vol. 6, 31 May 2023, pp. 17–17, https://doi.org/10.21037/pcm-22-67.

Khattab, Ahmed, et al. “Donor Cell Leukemia Following Allogeneic Hematopoietic Stem Cell Transplantation.” Journal of Hematology, vol. 12, no. 3, June 2023, pp. 138–144, https://doi.org/10.14740/jh1124.

Nieto, M., Firoozan, S., Patruni, S., & Saif, M. W. (2023). Secondary Malignancies after among Patients with Myelodysplastic Syndrome. International Journal of Cancer Medicine, 6(3), 142-148.

Khattab A, Patruni S, Abel S, Hasan S, Ludmir EB, Finley G, Monga D, Wegner RE, Verma V. Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma. J Gastrointest Oncol. 2019 Oct;10(5):918-927. doi: 10.21037/jgo.2019.07.02